An NSF International Company New Name for the Irish Medicines Board from 1 July 2025
Tuesday the 3rd June 2014
On 1 July 2014, the Irish Medicines Board (IMB) will change its name to the Health Products Regulatory Authority (HPRA).
Established in 1996, the IMB name is well known. However, over the last 18 years their regulatory remit has expanded to include other health products as well as a number of health related functions. In addition to human and veterinary medicines, they now have a role in regulating a range of areas including:
- Medical devices
- Controlled drugs
- Clinical trials
- Blood products and components
- Tissues and cells
- Cosmetic products
- The protection of animals used for scientific purposes
- Organs intended for transplantation
The new name more clearly reflects the wider scope of their work, functions and responsibilities across the health products sector.
Note: The IMB’s email addresses will change from “@imb.ie” to “@hpra.ie” on 1 July. However, the IMB versions will continue to work as normal for a transitional period thereafter.
